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(2OG) dependent oxygenases; prolyl-hydroxylation promotes HIF degradation via the ubiquitin-proteasome system, and asparaginyl-hydroxylation reduces the HIF transcriptional activity by blocking its interaction with p300 (2) . Sequence analyses suggest that Jmjd6 (3, (6) (7) (8) is a homologue of the HIF asparaginyl hydroxylase (Factor inhibiting HIF, FIH)(4, 5) (9) .
To investigate the function of Jmjd6 we assayed for proteins that interact with Jmjd6 in vivo using tandem-affinity purification coupled with MS analyses (10, 11) . A significant proportion (22/39) of the potential Jmjd6 interacting proteins are connected to RNA metabolism, processing and splicing (Table S1 ) with approximately a quarter being nuclear proteins possessing Arg-Ser (RS) domains (12/39). We confirmed interaction of Jmjd6 with U2 snRNP auxiliary factor 65 kDa subunit (U2AF65) (12) and cisplatin resistance-associated over-expressed protein (CROP) (13) , using GFP (green fluorescent protein) pull-down assays (14) , (Fig. 1A and S1A) in human HEK293T cells. Endogenous U2AF65 and Jmjd6 coimmunoprecipitate in HeLa cells with anti-U2AF65 antibody (Fig. S1B ). The interaction is disrupted upon treatment with RNase A (Fig. S2 ).
Jmjd6 has recently been reported to function as a histone arginine demethylase #(9).
However, we considered the possibility that arginine rich sequences present in RS domains (Fig. 1B) of many of the potential Jmjd6 binding proteins (see Table S1 ) may be a substrate of Jmjd6. RS domain sequences derived from U2AF65, CROP and LUC7-like2 (LUC7L2) were synthesised with dimethylated arginine residues, incubated with recombinant Jmjd6 in the presence of oxygen, ascorbate, Fe(II) and 2OG and analysed by MALDI MS. Peptides U2AF65 [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] (R35Me 2sym ), U2AF65 [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] (R33Me 2sym ) and LUC7L2 267-282 (R274Me 2sym ) did not show dimethyl arginineresidue demethylation (-14 shift in mass). Recombinant Jmjd6 did not demethylate arginine histone H4 and H3 fragment peptides. Instead a clear +16 Da. or +32 Da. mass shift relative to unreacted peptide was observed for RS-rich and histone peptides (Fig. S3, Fig. S4 ). This observation is consistent with the incorporation of one or two oxygen atom(s) into the peptide and has been previously observed by Chang et al. (9) .
No hydroxylation was observed in the absence of oxygen. The CROP 321-336 peptide did not contain any lysine residues and was not hydroxylated. The +16 Da. mass shift observed upon incubation of LUC7L2 267-278 was shown to be 2OG and Fe(II) dependent, and its formation was completely inhibited by an established 2OG and Fe(II) dependent oxygenase inhibitor, N-oxalylglycine (NOG) (15) , as well as the citric acid cycle intermediates succinate and fumarate (1 mM) (Fig. 1C) . Substitution of one or two of the proposed Fe(II) binding residues(4) with non-chelating residues (H187A and H187A-D189A) inactivated Jmjd6, implying an intact Fe(II) binding centre is required for catalysis. Incubation under an 18 O 2 atmosphere reveals the origin of the Jmjd6 introduced hydroxyl group to be from dioxygen gas (Fig. S5 ).
MS/MS analyses of LUC7L2 267-278 indicated oxidation of Lys-3, corresponding to
Lys-269 in LUC7L2 (Fig. S6) . 1 H NMR analyses confirmed the oxidation to be at C-5 on the hydrocarbon side-chain of Lys-269 (Fig. S7 ).
The shortest U2AF65 and LUC7L2 peptide ( Fig. IB) substrate with which we observed hydroxylation possessed 12-residues (LUC7L2 267-278 ). Shorter peptides were not observed (<5 %) to be hydroxylated under standard conditions. When LUC7L2 263- target lysines in LUC7L2 263-278 was individually substituted for an arginine-residue only a single hydroxylation is observed. The simultaneous substitution of both of these lysines to arginines prevented hydroxylation by Jmjd6 (Fig. S8 ) as did substitution with a tri-, di-and mono-methylated lysine-residue (Fig. S9) (Fig. 3A , S13, 3B). A similar splicing pattern was also observed when HeLa cells were treated with the hypoxia mimicking reagent, desferrioxamine (DFO) (22) , a general inhibitor of 2OG oxygenases (Fig. 3C ).
The -tropomyosin ( -TM) minigene construct (23) ( protein, produced a clear increase in the amount of 1-4 spliced isoform (Fig. 3D ).
Together these results imply a role for Jmjd6 in the regulation of alternative splicing.
Lysyl hydroxylation is the dominant oxidative catalytic activity of Jmjd6 (Fig. S14 ).
Jmjd6 catalysed arginine demethylation cannot be ruled-out but would have to occur at a level below our current levels of detection. Although synthetic histone sequences were found to be Jmjd6 substrates; our sub-cellular localisation and interaction analyses imply that histones, if interacting with Jmjd6 at all, are not a major focus of 
Conflict of Interest
C.J.S was a cofounder of ReOx, a company that aimed to exploit the hypoxic response for therapeutic benefit. or 500 gml -1 ) and incubated for 30 minutes on ice.
Supporting Online Material

Methods
Expression constructs
A monoclonal anti-U2AF65 antibody was used for immunoprecipitation experiments.
Control experiments were performed without adding the anti-U2AF65 antibody.
Extracts of 2x 10 7 HeLa cells (untransfected or 24 hours after transfection with pcDNA3:jmjd6) were prepared as described for GFP-pulldown and incubated with or without (control) anti-U2AF65 antibody for 1 hour under agitation at 4°C. Protein-G Sepharose 4 Fast Flow (GE Healthcare, NJ, USA) (100 l) was added for another hour. After 3 wash steps with 20 mM Tris/HCl, pH 8.0, 150 mM NaCl, the beads were re-suspended in SDS sample buffer and subjected to SDS-PAGE/Western blotting.
Cell culture, transfection and immunostaining experiments
HeLa cells and human embryonic kidney (HEK) 293T cells were cultured in Consistent with previous reports(4) immunofluorescence with anti-Jmjd6 antibody revealed nuclear localisation (Fig. S15) .
Cloning, expression and purification of human Jmjd6 (residues 1-343)
The gene encoding human Jmjd6 (residues 1-343) was cloned into the pET-28a(+) vector (Novagen) and was expressed in E. coli BL21-rosetta cells in 2TY growth medium supplemented with kanamycin (25 gml -1
) and chloramphenicol (30 gml -1 ).
Cells were grown at 37 °C until an OD 600 of 0.6; the temperature was then reduced to 25 °C and isopropyl -D-1-thiogalactopyranoside (IPTG) (0.5 mM) was added. Cells were then harvested 16-18 hours post-induction and lysed by sonication in tris buffer (50 mM, pH 7.0), NaCl (300 mM), tris(2-carboxyethyl) phosphine hydrochloride (TCEP) (0.2 mM) and glycerol (10 %) (lysis buffer). Purification of the N-terminally His 6 -tagged (N-terminus: MGSSHHHHHHSSGLVPRGSH) protein was carried out using nickel-affinity chromatography. Jmjd6 was eluted from the column using a gradient from 0 to 100% imidazole (500 mM). Fractions were analysed by SDS-PAGE and those containing protein of the correct molecular weight and the best purity were pooled and concentrated using a 10,000 MWCO filter (Millipore). The protein solution was buffer-exchanged into lysis buffer and concentrated to 10-20 mgml -1 measured by a NanoDrop ® ND-1000 spectrophotometer (LabTech International, UK). Further purification of Jmjd6 (>95 % as determined by SDS-PAGE analysis) was performed using size-exclusion chromatography (SEC), using a Superdex-75 ™ (300 ml, GE Healthcare, UK) preparative grade column.
The H187A and H187A-D189A Jmjd6 variants were created from the wild-type construct (pET-28a(+)-Jmjd6 (residues 1-343)) using the QuikChange ® II Site-directed mutagenesis kit (Stratagene). The integrity of the mutations was confirmed by DNA sequencing (Geneservice, Oxford).
Finding a substrate for Jmjd6
Standard assays consisted of the substrate mixture: substrate (100 M), 2OG (500 M), ascorbate (100 M) in Tris (50 mM, pH 7.5); and the enzyme mixture: 
MS/MS analysis of hydroxylated LUC7L2 267-278
MS/MS analyses were carried out using a Ultraflex III MALDI TOF-TOF (Bruker Daltonics) mass spectrometer and experiments were acquired using the potential LIFT 1 H and 2D COSY NMR experiments were performed on a Bruker AVII 500 spectrometer using a 1 mm microprobe.
O 2 dioxygen experiment with LUC7L2 267-278
The hydroxylation of LUC7L2 267-278 by Jmjd6, under standard assay conditions, was performed under an atmosphere of 18 O 2 . A rubber septum sealed reaction vessel, containing the substrate mixture, was evacuated and flushed with argon no less than three times before being filled with 18 O 2 gas (>98 % CK gases). The reaction was initiated by injecting the enzyme mixture (Jmjd6 and Fe(II)) through the septum into the vessel. The reaction was carried out for one hour before it was quenched by freezing and then addition of CF 3 CO 2 H (0.1 %). Products were analysed by MALDI-TOF mass spectrometry as above.
Peptide synthesis
All peptides tested as potential substrates of Jmjd6 were synthesised in-house using a Predicted masses were confirmed by MALDI-TOF mass spectrometry.
Substrate selectivity assays
Standard assay conditions were used and are described above. To determine the pH profile of Jmjd6 standard peptide assays were performed over a pH range of 6 to 9.
Buffers used were piperazine-N,N'-bis(ethanesulfonic acid) (PIPES) (pH 6.0 and 6.5), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.0 to 8.0) and N,N-bis(2-hydroxyethyl) glycine (BICINE) (pH 8.5 and 9.0). Inhibition assays were performed under identical conditions as described for the standard assays except either succinate (1mM) or fumarate (1 mM) were included in the substrate mixture.
In-gel digestions with LysC protease
Immunoprecipitated U2AF65 and recombinant U2AF65 were separated 1D SDS-PAGE (12 % acrylamide), the gel was then stained with Coomassie Blue using Colloidal Blue Staining Kit (Invitrogen), and protein bands corresponding to the proteins of interest were excised and digested with LysC protease (Roche) according to standard protocol (26) . The extracted peptides were desalted and concentrated using RP-C18 StageTip columns (27) and the eluted peptides used for mass spectrometric analysis.
Mass spectrometric analysis of recombinant and endogenous U2AF65
MS experiments on recombinant and endogenous U2AF65 were performed using a nanoflow high-performance liquid chromatography (HPLC) system (Agilent Technologies 1200, Waldbronn, Germany) connected to a hybrid LTQ-Orbitrap XL (Thermo Fisher Scientific, Bremen, Germany) equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, Denmark) as described (28) . The peptide mixtures were loaded onto a 15 cm analytical column (75 μm inner diameter) packed in-house with 3μm reverse-phased, fully endcapped C18 beads (Reprosil-AQ Pur, Dr. resolution of R=60,000 at m/z 400 (after accumulation to a "target value" of 1,000,000 in the linear ion trap). The ten most intense peptide ions in each survey scan with an ion intensity above 500 counts and a charge state 2 were sequentially isolated to a target value of 5,000 and fragmented in the linear ion trap by collisionally induced dissociation (CID/CAD). All peaks selected for fragmentation were automatically put on an exclusion list for 90 seconds, which ensured that the same ion would not be selected for fragmentation more than once. For optimal duty cycle the fragment ion spectra were recorded in the LTQ mass spectrometer "in parallel" with the orbitrap full scan detection. For all survey scan measurements with the orbitrap detector a lock-mass ion from ambient air (m/z 391.284286, 429.08875, and 445.120025) was used for internal calibration as described (29) ensuring an overall sub-ppm mass accuracy for all detected peptides. For all mass spectrometric experiments data was saved in RAW file format (Thermo Scientific, Bremen, Germany) using the Xcalibur 2.0 with Tune 2.4. All data was analyzed using in-house written software MaxQuant.
Identification of U2AF65 peptides
The data analysis was performed with the MaxQuant software as described in (30) supported by Mascot as the database search engine for peptide identifications. MS/MS peak lists were filtered to contain at most six peaks per 100 Dalton intervals and searched by Mascot (www.matrixscience.com) against a concatenated forward and reversed version of the IPI human database (version 3.37, www.ebi.ac.uk). Protein sequences of common contaminants, e.g. keratins, were added to the database. The initial mass tolerance in MS mode was set to 5 ppm and MS/MS mass tolerance was 0.5 Da. Cysteine carbamidomethylation was searched as a fixed modification, whereas N-acetyl protein, N-pyroglutamine, oxidized methionine, and lysine hydroxylation were searched as variable modifications. Relative peptide quantitation was based on extracted ion chromatograms (XICs) with a mass window of +/-5 mDa.
Furthermore, peptide assignments were statistically evaluated in a Bayesian model based on sequence length and Mascot score. We only accepted peptides with a false discovery rate (FDR) of less than 1%, estimated based on the number of accepted 'reverse' hits. Due to the technical limitations of the MS analyses on the LysC digests from intact proteins, we are unable to obtain complete coverage of the target proteins (including in the RS domain region) via our current MS system. Therefore the number of hydroxylated residues may be greater than those we have identified.
Effect of RNAi-mediated depletion of Jmjd6 on alternative splicing
The -TM minigene construct contains 6 tandem URE copies to increase skipping of exon 3 in HeLa cells(31) and has been described elsewhere (31) . Supporting Tables 1   Table S1 . Potential interacting proteins of Jmjd6, as identified by tandemaffinity purification and mass spectrometry.
Supporting Figures 1-15
Fig. S1. (A) GFP-pulldown demonstrates interaction of Jmjd6 with U2AF65.
Lysates Because of the highly basic amino acids in the RS-domain sequences we have been unable to detect sequence with some potential target hydroxylation sites, thus it is likely that there are hydroxylation sites additional to those we have detected in recombinant and endogenous U2AF65. dependent manner. All the peptide assays described in this paper were performed using C-terminally truncated Jmjd6 (residues 1-343). Full-length (residues 1-403) and protein with C-and N-terminal truncations (residues 25-338) were also found to hydroxylate peptides to a similar extent, and no demethylation of arginine residues was observed. 
